Occurrence of T-cell lymphoma in a patient with acute myelogenous leukemia.
We describe a patient with AML with a monocytic component who developed a T-lymphoblastic lymphoma. Lymphoma was diagnosed 9 months following AML diagnosis. To our knowledge, this is the first report of phenotypically documented T-cell lymphoma following AML. The questions relating to the pathogenesis of the two malignancies are discussed.
Thomas
X
X
Service d'Hématologie, Hôpital Edouard Herriot, Lyon, France.
Anglaret
B
B
Treille-Ritouet
D
D
Bastion
Y
Y
Fiere
D
D
Archimbaud
E
E
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001752:Blast Crisis; D001853:Bone Marrow / Q000473:pathology; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D016130:Immunophenotyping; D007621:Karyotyping; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D016399:Lymphoma, T-Cell / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D016609:Neoplasms, Second Primary / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D010996:Pleural Effusion; D013601:T-Lymphocytes / Q000276:immunology / Q000473:pathology